The Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Japanese Patients after Allogeneic Stem Cell Transplantation
暂无分享，去创建一个
H. Matsuoka | G. Ohji | H. Minami | T. Murayama | A. Kitao | K. Yakushijin | S. Kawamoto | Y. Funakoshi | Y. Miyata | T. Koyama | H. Sakai | S. Matsumoto | S. Nagao | M. Watanabe | M. Saeki | Y. Hirakawa | R. Sakai | W. Hojo | M. Ito | Y. Saito